Alcon Inc
-1.03 (-1.33%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 777,998
Bid Price
Ask Price
News -
Day High 76.43


52 Week Range


Day Low 75.30
Company Name Stock Ticker Symbol Market Type
Alcon Inc ALC NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.03 -1.33% 76.20 20:00:00
Open Price Low Price High Price Close Price Prev Close
75.30 75.30 76.43 76.25 77.23
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
11,138 777,998 $ 76.03 $ 59,152,370 - 55.21 - 81.975
Last Trade Time Type Quantity Stock Price Currency
19:00:00 17,992 $ 76.25 USD


Draw Mode:

Alcon Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 37.34B 490.09M 490.09M $ 8.29B $ 547.21M 0.76 64.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 0.11 0.28% 05/03/22 - -

more financials information »

Alcon News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ALC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week73.9777.9073.6575.84816,6172.233.01%
1 Month70.7677.9069.6774.18809,0205.447.69%
3 Months64.8377.9062.7269.59894,31411.3717.54%
6 Months77.2878.2255.2166.10934,327-1.08-1.4%
1 Year77.4781.97555.2169.64883,600-1.27-1.64%
3 Years58.9888.7839.3766.45982,47717.2229.2%
5 Years58.24588.7839.3764.371,040,80417.9630.83%

Alcon Description

Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.